VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemesMarketEarningsCompareWatchlistInsider
ATAIAtai Beckley N.V
$4.06$1.5B
Research
Overview
Valuation
ValuationTargetsPrice
Financials
RevenueEarningsP/ERatiosDividend
Ownership
Holders
Tools
Total ReturnDCA Calculator
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

Follow VCP Scanner on XFollow VCP Scanner on LinkedIn
© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist

ATAI logoAtai Beckley N.V(ATAI)Earnings, Financials & Key Ratios

ATAI•NASDAQ
Price updated Jun 19, 2026
SectorHealthcareIndustryPharmaceuticalsSub-IndustryClinical-Stage Biopharma Developers
AboutAtai Beckley NV is a clinical-stage biopharmaceutical company. It engages in the treatment of mental health disorders. The company was founded by Christian Angermayer, Florian Brand, Srinivas Rao and Lars Christian Wilde in June 2018 and is headquartered in Amstelveen, Netherlands.Show more
  • Revenue$4M+1227.6%
  • EBITDA-$99M+3.4%
  • Net Income-$660M-342.2%
  • EPS (Diluted)-2.91-212.9%
  • Gross Margin75.25%+240.5%
  • EBITDA Margin-2414.99%+92.7%
  • Operating Margin-2439.74%+92.7%
  • Net Margin-16142.02%+66.7%
  • ROE-389.92%-371.3%

ATAI Key Insights

Atai Beckley N.V (ATAI) fundamental analysis — strengths, weaknesses & financial health based on data analysis

✓Strengths

  • ✓Company is almost debt free

✗Weaknesses

  • ✗Profits declining 31.2% over 5 years
  • ✗Negative free cash flow
  • ✗Low quality earnings: Net income not backed by cash flow
  • ✗Shares diluted 41.4% in last year
  • ✗Trading more than 30% below 52-week high
  • ✗Low asset turnover indicates capital-intensive operations

* These insights are generated automatically based on available financial data. Please conduct your own research before making investment decisions.

Get notified when ATAI posts new earnings or crosses analyst targets

Free. No account needed. Unsubscribe any time.

Free. Unsubscribe any time.

ATAI Price & Volume

Atai Beckley N.V (ATAI) stock price & volume — 10-year historical chart

Loading chart...

ATAI Growth Metrics

Atai Beckley N.V (ATAI) revenue, earnings & EPS growth — 3, 5 & 10-year CAGR

Revenue CAGR

10 Years-
5 Years-
3 Years159.87%
TTM87.22%

Profit CAGR

10 Years-
5 Years-
3 Years-
TTM-345.27%

EPS CAGR

10 Years-
5 Years-
3 Years-
TTM-229.67%

Return on Capital

10 Years-56.27%
5 Years-46.8%
3 Years-47.53%
Last Year-47.34%

ATAI Recent Earnings

Atai Beckley N.V (ATAI) EPS & revenue vs analyst estimates — last 4 quarters

Full history →
●Beat EPS 6/12 qtrs (50%)●Beat Revenue 3/12 qtrs (43%)
Q2 2026Latest
May 12, 2026
Metric
Actual
Est
EPS
$0.08+27.3%
$0.11
Rev
$954,000+339.4%
$217,111
Q2 2026
Mar 6, 2026
Metric
Actual
Est
EPS
$0.05+58.3%
$0.12
Rev
$1M+255.3%
$300,000
Q4 2025
Nov 12, 2025
Metric
Actual
Est
EPS
$0.28-133.3%
$0.12
Rev
$749,000+226.8%
$229,170
Q3 2025
Aug 14, 2025
Metric
Actual
Est
EPS
$0.14-16.7%
$0.12
Rev
$719,000
—
QuarterDateEPS (Act vs Est)Revenue (Act vs Est)
Q2 2026LatestMay 12, 2026
$0.08vs $0.11+27.3%
$954,000vs $217,111+339.4%
Q2 2026Mar 6, 2026
$0.05vs $0.12+58.3%
$1Mvs $300,000+255.3%
Q4 2025Nov 12, 2025
$0.28vs $0.12-133.3%
$749,000vs $229,170+226.8%
Q3 2025Aug 14, 2025
$0.14vs $0.12-16.7%
$719,000
Based on last 12 quarters of dataView full earnings history →

ATAI Peer Comparison

Atai Beckley N.V (ATAI) competitors in Clinical-Stage Biopharma Developers — business model, growth, and fundamentals comparison

Select Columns
Stock Universe
Valuation
Growth
Profitability
Financial Health
Dividends & Buybacks
Price Performance
Technical
Fundamentals ($)
Sector-Specific
Institutional Holdings
CompanyMarket CapStock PriceP/E Ratio (TTM)Revenue Growth 1YNet MarginReturn on Equity (ROE)FCF YieldDebt / Equity
CMPS logoCMPSCOMPASS Pathways plcDirect Competitor1.2B12.53-4.07-151.02%
MNMD logoMNMDMind Medicine (MindMed) Inc.Direct Competitor2.04B20.69-10.04-102.48%
CYBN logoCYBNCybin Inc.Direct Competitor303.86M6.09-13.66-81%
SILO logoSILOSilo Pharma, Inc.Product Competitor5.54M6.12-0.82-67.17%-88.41%
ENVB logoENVBEnveric Biosciences, Inc.Product Competitor764.17K1.28-0.04-220.99%
JAZZ logoJAZZJazz Pharmaceuticals plcSupply Chain14.09B224.66-38.474.88%0.66%0.71%1.26
INVA logoINVAInnoviva, Inc.Supply Chain1.66B22.496.8218.52%118.91%47.59%0.23
PRAX logoPRAXPraxis Precision Medicines, Inc.Supply Chain8.15B282.31-20.94-100%-43.02%0.00

Compare ATAI vs Peers

Atai Beckley N.V (ATAI) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.

Closest Rival

vs CMPS

Most directly comparable listed peer for ATAI.

Scale Benchmark

vs JAZZ

Larger-name benchmark to compare ATAI against a more recognizable public peer.

Peer Set

Compare Top 5

vs CMPS, MNMD, CYBN, SILO

ATAI Income Statement

Atai Beckley N.V (ATAI) annual income statement — 10-year revenue, gross profit & net income history

10Y historyFree accessUpdated daily
MetricDec'19Dec'20Dec'21Dec'22Dec'23Dec'24Dec'25TTM
Sales/Revenue
0020.38M233K314K308K4.09M3.49M
Revenue Growth %
----98.86%34.76%-1.91%1227.6%87.22%
Cost of Goods Sold
6K24K47K168K319K473K1.01M627K
COGS % of Revenue
--0.23%72.1%101.59%153.57%24.75%-
Gross Profit
-6K▲ 0%
-24K▼ 300.0%
20.33M▲ 84804.2%
65K▼ 99.7%
-5K▼ 107.7%
-165K▼ 3200.0%
3.08M▲ 1964.8%
2.86M▲ 0%
Gross Margin %
--99.77%27.9%-1.59%-53.57%75.25%82.02%
Gross Profit Growth %
--300%84804.17%-99.68%-107.69%-3200%1964.85%-
Operating Expenses
17.84M104.14M140.65M144.5M125.47M102.53M102.84M130.45M
OpEx % of Revenue
--690.29%62015.02%39957.32%33287.66%2514.99%-
Selling, General & Admin
5.08M80.71M92.75M70.35M63.58M47.54M49.78M68.46M
SG&A % of Revenue
--455.17%30193.13%20249.04%15436.36%1217.31%-
Research & Development
12.76M23.43M47.91M74.14M61.88M54.98M53.06M61.99M
R&D % of Revenue
--235.12%31821.89%19708.28%17851.3%1297.68%-
Other Operating Expenses
00000000
Operating Income
-17.85M▲ 0%
-104.16M▼ 483.6%
-120.33M▼ 15.5%
-144.43M▼ 20.0%
-125.47M▲ 13.1%
-102.69M▲ 18.2%
-99.76M▲ 2.9%
-127.59M▲ 0%
Operating Margin %
---590.52%-61987.12%-39958.92%-33341.23%-2439.74%-3658.03%
Operating Income Growth %
--483.61%-15.52%-20.03%13.13%18.16%2.85%-
EBITDA
-17.84M-104.14M-120.28M-144.26M-125.15M-102.22M-98.75M-126.97M
EBITDA Margin %
---590.29%-61915.02%-39857.32%-33187.66%-2414.99%-3640.05%
EBITDA Growth %
--483.67%-15.5%-19.94%13.25%18.32%3.39%-29.08%
D&A (Non-Cash Add-back)
6K24K47K168K319K473K1.01M627K
EBIT
-17.85M-104.16M-120.33M-144.43M-125.47M-102.69M-99.76M-127.59M
Net Interest Income
23K71K205K-375K-809K-2.35M316K1.11M
Interest Income
23K71K205K548K1.85M778K1.48M1.37M
Interest Expense
000923K2.66M3.12M1.16M264K
Other Income/Expense
-6.53M-74.16M-57.91M-6.76M82.59M-48.24M-560.09M-535.79M
Pretax Income
-24.38M▲ 0%
-178.32M▼ 631.4%
-178.23M▲ 0.0%
-151.19M▲ 15.2%
-42.88M▲ 71.6%
-150.93M▼ 252.0%
-659.85M▼ 337.2%
-663.38M▲ 0%
Pretax Margin %
---874.72%-64887.55%-13655.73%-49003.25%-16137.17%-19018.9%
Income Tax
2K305K-3.99M6.23M1.02M-881K298K105K
Effective Tax Rate %
-0.01%-0.17%2.24%-4.12%-2.37%0.58%-0.05%-0.02%
Net Income
-14.14M▲ 0%
-169.84M▼ 1101.3%
-167.81M▲ 1.2%
-152.38M▲ 9.2%
-40.22M▲ 73.6%
-149.27M▼ 271.1%
-660.05M▼ 342.2%
-663.4M▲ 0%
Net Margin %
---823.56%-65401.29%-12810.19%-48463.96%-16142.02%-19019.44%
Net Income Growth %
--1101.32%1.2%9.19%73.6%-271.09%-342.19%-345.27%
Net Income (Continuing)
-24.38M-178.63M-174.24M-157.42M-43.9M-150.05M-660.15M-663.48M
Discontinued Operations
00000000
Minority Interest
1.03M4.55M9.05M5.03M1.35M257K127K96K
EPS (Diluted)
-0.09▲ 0%
-1.11▼ 1097.4%
-1.04▲ 6.3%
-0.98▲ 5.8%
-0.25▲ 74.5%
-0.93▼ 272.0%
-2.91▼ 212.9%
-2.93▲ 0%
EPS Growth %
--1097.41%6.31%5.77%74.49%-272%-212.9%-229.67%
EPS (Basic)
-0.09-1.11-1.04-0.98-0.25-0.93-2.91-
Diluted Shares Outstanding
152.57M152.57M160.68M155.72M158.83M160.16M226.53M226.53M
Basic Shares Outstanding
152.57M152.57M160.68M155.72M158.83M160.16M226.53M226.53M
Dividend Payout Ratio
--------

ATAI Balance Sheet

Atai Beckley N.V (ATAI) balance sheet — assets, liabilities & shareholders' equity

MetricDec'19Dec'20Dec'21Dec'22Dec'23Dec'24Dec'25TTM
Total Current Assets
39.15M99.55M375.08M287.14M185.59M80.13M275.68M250.07M
Cash & Short-Term Investments
30.06M97.25M362.27M273.11M179.26M62.33M256.04M230.77M
Cash Only
30.06M97.25M362.27M190.61M45.03M17.5M85.3M43.1M
Short-Term Investments
00082.5M134.22M44.83M170.74M187.66M
Accounts Receivable
8.7M1.29M6.32M5.63M2.26M1.35M14.43M14.71M
Days Sales Outstanding
--113.198.82K2.62K1.6K1.29K1.09K
Inventory
00000000
Days Inventory Outstanding
--------
Other Current Assets
207K554K756K1.75M846K10.78M946K4.59M
Total Non-Current Assets
22.97M12M39.08M18.3M107.89M79.26M34.86M14.81M
Property, Plant & Equipment
21K71K149K1.15M2.2M3.87M4.01M3.86M
Fixed Asset Turnover
--136.75x0.20x0.14x0.08x1.02x0.72x
Goodwill
00000331K331K9.86M
Intangible Assets
00001.77M3.25M11.59M0
Long-Term Investments
22.95M10.02M27.76M6.75M91.66M70.97M900K160.82M
Other Non-Current Assets
01.91M11.18M10.39M12.25M850K210K292K
Total Assets
62.12M▲ 0%
111.55M▲ 79.6%
414.17M▲ 271.3%
305.44M▼ 26.3%
293.48M▼ 3.9%
159.39M▼ 45.7%
310.54M▲ 94.8%
264.88M▲ 0%
Asset Turnover
--0.05x0.00x0.00x0.00x0.01x0.01x
Asset Growth %
-79.58%271.29%-26.25%-3.92%-45.69%94.83%139.23%
Total Current Liabilities
1.61M12.3M20.93M19.9M20.12M24.95M23.48M24.96M
Accounts Payable
006M2.4M4.59M2.62M4.91M10.79M
Days Payables Outstanding
--46.63K5.21K5.25K2.02K1.77K3.65K
Short-Term Debt
000009.36M271K310K
Deferred Revenue (Current)
0000001.52M3M
Other Current Liabilities
1.48M10.2M265K718K1.1M2.65M11.11M12.31M
Current Ratio
24.36x8.09x17.92x14.43x9.22x3.21x11.74x10.02x
Quick Ratio
24.36x8.09x17.92x14.43x9.22x3.21x11.74x10.02x
Cash Conversion Cycle
--------2.57K
Total Non-Current Liabilities
729K3.88M7.27M19.78M29.04M17.88M65.06M41.13M
Long-Term Debt
157K2.18M743K15.12M17.88M14.13M00
Capital Lease Obligations
00044K990K732K1.8M8.54M
Deferred Tax Liabilities
00000017.82M17.82M
Other Non-Current Liabilities
572K1.71M6.53M4.62M10.18M3.02M45.44M39.44M
Total Liabilities
2.34M16.18M28.21M39.67M49.16M42.83M88.54M66.1M
Total Debt
157K2.18M743K15.34M19.14M24.71M2.07M2M
Net Debt
-29.91M-95.07M-361.52M-175.27M-25.89M7.2M-83.23M-41.1M
Debt / Equity
0.00x0.02x0.00x0.06x0.08x0.21x0.01x0.01x
Debt / EBITDA
--------0.02x
Net Debt / EBITDA
-------0.32x
Interest Coverage
----156.48x-47.24x-32.87x-85.85x-483.30x
Total Equity
59.78M▲ 0%
95.37M▲ 59.5%
385.96M▲ 304.7%
265.77M▼ 31.1%
244.32M▼ 8.1%
116.55M▼ 52.3%
222M▲ 90.5%
198.78M▲ 0%
Equity Growth %
-59.53%304.7%-31.14%-8.07%-52.29%90.47%115.7%
Book Value per Share
0.390.632.401.711.540.730.980.88
Total Shareholders' Equity
58.75M90.82M376.91M260.74M242.96M116.3M221.87M198.68M
Common Stock
6.57M8.36M18M18.56M18.57M18.79M3.63M3.66M
Retained Earnings
-19.46M-189.31M-357.8M-510.19M-550.94M-700.21M-1.36B-1.39B
Treasury Stock
00000000
Accumulated OCI
-1.43M5.82M-8.34M-21.7M-19.46M-18.47M-20.93M-20.6M
Minority Interest
1.03M4.55M9.05M5.03M1.35M257K127K96K

ATAI Cash Flow Statement

Atai Beckley N.V (ATAI) cash flow — operating, investing & free cash flow history

MetricDec'19Dec'20Dec'21Dec'22Dec'23Dec'24Dec'25TTM
Cash from Operations
-7.85M-20.77M-63.25M-104.47M-84.12M-82.44M-102.67M-106.6M
Operating CF Margin %
---310.39%-44835.62%-26789.17%-26765.26%-2511.01%-
Operating CF Growth %
--164.67%-204.57%-65.18%19.48%2%-24.55%-124.36%
Net Income
-24.38M-178.63M-174.24M-157.42M-43.9M-150.05M-660.05M-663.4M
Depreciation & Amortization
6K24K47K168K319K473K1.01M627K
Stock-Based Compensation
57K67.16M63.36M42.38M32.98M25.49M011.43M
Deferred Taxes
7.54M56.35M39.13M5.07M0000
Other Non-Cash Items
9.06M29.88M16.06M8.67M-80.99M50.85M562.84M547.96M
Working Capital Changes
-126K4.45M-7.6M-3.33M7.47M-9.2M-6.47M-3.15M
Change in Receivables
00000000
Change in Inventory
00000000
Change in Payables
249K1.7M2.3M-3.03M2.14M-1.87M-1.7M4.05M
Cash from Investing
-9.03M-28.27M-81.28M-86.85M-53.3M59.17M-109.13M-120.02M
Capital Expenditures
-19K-59K-1.13M-773K-259K-95K-10.87M-10.9M
CapEx % of Revenue
--5.54%331.76%82.48%30.84%265.79%312.61%
Acquisitions
-456K-2.09M-52.94M0-443K359K4.64M5.67M
Investments
--------
Other Investing
-7.32M-2.2M-2.6M-3.25M-5.84M-8.1M-13M-17.91M
Cash from Financing
40.39M113.05M409.86M20.79M-8.36M5.37M269.48M213.28M
Debt Issued (Net)
032.5M1.59M15M05M7.71M29.76M
Equity Issued (Net)
42.68M82.44M405.86M600K0535K283.43M198.23M
Dividends Paid
00000000
Share Repurchases
0000000-3.56M
Other Financing
-2.29M-1.89M2.42M5.18M-8.36M-161K-21.66M-14.71M
Net Change in Cash
23.14M▲ 0%
67.18M▲ 190.3%
265.02M▲ 294.5%
-171.65M▼ 164.8%
-145.58M▲ 15.2%
-17.53M▲ 88.0%
57.8M▲ 429.7%
-15.19M▲ 0%
Free Cash Flow
-7.87M▲ 0%
-20.82M▼ 164.8%
-64.37M▼ 209.1%
-105.49M▼ 63.9%
-84.71M▲ 19.7%
-82.53M▲ 2.6%
-103.58M▼ 25.5%
-117.19M▲ 0%
FCF Margin %
---315.93%-45275.11%-26977.07%-26796.1%-2533.04%-3359.77%
FCF Growth %
--164.78%-209.12%-63.87%19.7%2.57%-25.5%-50.42%
FCF per Share
-0.05-0.14-0.40-0.68-0.53-0.52-0.46-0.52
FCF Conversion (FCF/Net Income)
0.55x0.12x0.38x0.69x2.09x0.55x0.16x0.18x
Interest Paid
00001.92M2.16M0203K
Taxes Paid
00001.48M411K055K

ATAI Key Ratios

Atai Beckley N.V (ATAI) financial ratios — P/E, ROE, debt and 30+ core market and balance-sheet ratios

Metric202020212022202320242025TTM
Return on Equity (ROE)
-218.94%-69.73%-46.76%-15.77%-82.73%-389.92%-366.21%
Return on Invested Capital (ROIC)
-517.81%-729.68%-188.5%-60.92%-45.02%-57%-73.59%
Gross Margin
-99.77%27.9%-1.59%-53.57%75.25%82.02%
Net Margin
--823.56%-65401.29%-12810.19%-48463.96%-16142.02%-19019.44%
Debt / Equity
0.02x0.00x0.06x0.08x0.21x0.01x0.01x
Interest Coverage
---156.48x-47.24x-32.87x-85.85x-483.30x
FCF Conversion
0.12x0.38x0.69x2.09x0.55x0.16x0.18x
Revenue Growth
---98.86%34.76%-1.91%1227.6%87.22%
Related:ATAI Dividend History·ATAI Revenue History·ATAI Price History·ATAI P/E History·ATAI Financial Ratios·ATAI Institutional Holders

ATAI SEC Filings & Documents

Atai Beckley N.V (ATAI) SEC filings — annual & quarterly reports (10-K, 10-Q)

8-K Announcements

6
Material company update

Dec 5, 2025·SEC

Material company update

Nov 12, 2025·SEC

Material company update

Nov 5, 2025·SEC

10-K Annual Reports

2
FY 2025

Mar 17, 2025·SEC

FY 2024

Mar 28, 2024·SEC

10-Q Quarterly Reports

6
FY 2025

Nov 12, 2025·SEC

FY 2025

Aug 14, 2025·SEC

FY 2025

May 14, 2025·SEC

ATAI Frequently Asked Questions

Atai Beckley N.V (ATAI) stock FAQ — growth, dividends, profitability & financials explained

Growth & Financials

Atai Beckley N.V (ATAI) reported $3.5M in revenue for fiscal year 2025.

Atai Beckley N.V (ATAI) grew revenue by 1227.6% over the past year. This is strong growth.

Atai Beckley N.V (ATAI) reported a net loss of $663.4M for fiscal year 2025.

Dividend & Returns

Atai Beckley N.V (ATAI) has a return on equity (ROE) of -389.9%. Negative ROE indicates the company is unprofitable.

Atai Beckley N.V (ATAI) had negative free cash flow of $117.2M in fiscal year 2025, likely due to heavy capital investments.

What if you invested $1,000 in ATAI back in 2019?

Total return calculator · dividends reinvested · 7+ years of data

See returns →

How much would $100/month in ATAI be worth today?

Dollar cost averaging calculator · DCA vs lump sum

Calculate →